-
EP1623230
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1623230
| EP1623230 - DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH G-PROTEIN-COUPLED RECEPTOR GPR39 (GPR39) [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.03.2010 Database last updated on 24.08.2024 | Most recent event Tooltip | 19.03.2010 | Application deemed to be withdrawn | published on 21.04.2010 [2010/16] | Applicant(s) | For all designated states Bayer Schering Pharma Aktiengesellschaft Müllerstrasse 178 13353 Berlin / DE | [2009/38] |
| Former [2009/37] | For all designated states Bayer Schering Pharma AG Müllerstrasse 178 13353 Berlin / DE | ||
| Former [2006/06] | For all designated states Bayer HealthCare AG 51368 Leverkusen / DE | Inventor(s) | 01 /
GOLZ, Stefan Bückmannsmühle 46 45326 Essen / DE | 02 /
BRÜGGEMEIER, Ulf Leysiefen 20 42799 Leichlingen / DE | 03 /
SUMMER, Holger Katernberger Schulweg 3 42113 Wuppertal / DE | 04 /
THIELE, Ralf Ebbinghauser Str. 13 33178 Borchen / DE | [2006/06] | Application number, filing date | 04728789.1 | 22.04.2004 | [2006/06] | WO2004EP04279 | Priority number, date | EP20030010095 | 05.05.2003 Original published format: EP 03010095 | [2006/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004099782 | Date: | 18.11.2004 | Language: | EN | [2004/47] | Type: | A2 Application without search report | No.: | EP1623230 | Date: | 08.02.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.11.2004 takes the place of the publication of the European patent application. | [2006/06] | Search report(s) | International search report - published on: | EP | 16.06.2005 | Classification | IPC: | G01N33/68 | [2006/06] | CPC: |
G01N33/6893 (EP,US);
A61P11/00 (EP);
A61P15/00 (EP);
A61P25/00 (EP);
A61P3/00 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C07K14/705 (EP,US);
C12Q1/6883 (EP,US);
C12Q1/6886 (EP,US);
G01N33/5008 (EP,US);
G01N33/502 (EP,US);
G01N33/5091 (EP,US);
G01N33/74 (EP,US);
A61K38/00 (EP,US);
C12Q1/6811 (EP,US);
C12Q2600/136 (EP,US);
C12Q2600/158 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/06] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | DIAGNOSTIKA UND THERAPEUTIKA FÜR KRANKHEITEN, DIE MIT GPR39 (G-PROTEIN COUPLED RECEPTOR GPR39) ASSOZIIERT SIND | [2006/06] | English: | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH G-PROTEIN-COUPLED RECEPTOR GPR39 (GPR39) | [2006/06] | French: | APPROCHE DIAGNOSTIQUE ET THERAPEUTIQUE DES MALADIES ASSOCIEES AU RECEPTEUR GPR39 (GPR39) COUPLE A UNE PROTEINE G | [2006/06] | Entry into regional phase | 05.12.2005 | National basic fee paid | 16.12.2005 | Designation fee(s) paid | 16.12.2005 | Examination fee paid | Examination procedure | 16.12.2005 | Examination requested [2006/06] | 03.11.2009 | Application deemed to be withdrawn, date of legal effect [2010/16] | 04.12.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2010/16] | Fees paid | Renewal fee | 02.05.2006 | Renewal fee patent year 03 | 02.05.2007 | Renewal fee patent year 04 | 22.03.2008 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.04.2009 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XD]WO0181634 (MILLENNIUM PHARM INC [US], et al) [XD] 1-26 * the whole document, see especially p. 12-23 and claims *; | [XY]WO02061087 (LIFESPAN BIOSCIENCES INC [US], et al) [X] 1-17,19-21,24-26 * the whole document, see especially paragraphs 15, 47, 112, 134, 237-238, 263-266 and pages 11-12 * [Y] 18; | [DX]WO02071928 (MILLENNIUM PHARM INC [US], et al) [DX] 1-26 * the whole document, see especially p. 1-19 and 72-76 *; | [X]WO03025138 (EOS BIOTECHNOLOGY INC [US], et al) [X] 1-26 * the whole document, see especially p. 1-80 *; | [PDXY]US6710170 (XU JIANGCHUN [US], et al) [PDX] 19-26 * the whole document, see especially parasgraphs 2, 8, 101, 134, 162, 209 and claims *[PY] 18 |